Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database.

Wang, Sen; Gao, Wei-Cheng; Chen, San-San; Bai, Liang; Luo, Li; Zheng, Xiang-Guang; Luo, You

Wang, Sen; Gao, Wei-Cheng; Chen, San-San; Bai, Liang; Luo, Li; Zheng, Xiang-Guang; Luo, You.

Afiliação

Wang S; Department of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Gao WC; Department of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Chen SS; Department of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Bai L; Department of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Luo L; Department of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Zheng XG; Department of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Luo Y; Department of Urology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

Onco Targets Ther ; 10: 5311-5315, 2017.

Article em En | MEDLINE | ID: mdl-29184417

Palavras-chave

adrenalectomy; adrenocortical carcinoma; metastasis; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google